Authors of a case study reported severe adult-onset Still disease manifestations in a patient with long-term sequelae of COVID-19.
Researchers identified metabolic changes related to rheumatoid arthritis pathogenesis occurring in the blood before disease diagnosis.
Aside from autoimmunity, an analysis of the tie between psoriasis and thyroid diseases is provided.
The patient, who had suffered a traumatic brain injury approximately 8 months prior, presented to the emergency department complaining of increasing dizziness as well as sleepwalking frequency.
The adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in patients with RA was validated.
The efficacy and safety of a treat-to-target strategy using MTX and biologic DMARDs for patients with elderly-onset RA was investigated.
Evidence of the first in vitro assay with potential to predict a patient’s response in a drug-specific manner is provided.
The effect of a nonmedical switch from rituximab originator to a rituximab biosimilar in patients with rheumatoid arthritis was assessed.
Researchers assessed the role of trimethoprim/sulfametoxazole in reducing relapse rate in patients with granulomatosis with polyangiitis and infection risk in patients with ANCA-associated vasculitis.
New study is the first to characterize pegloticase use in the dialysis population.
In all 6 cases, symptoms developed 6 to 13 days after vaccination.
Fully vaccinated individuals can travel within the US without having the need for COVID-19 testing or post-travel self-quarantine.
In the final analysis of the OPAL Balance study, researchers assessed the safety, tolerability, and efficacy of tofacitinib in patients with active psoriatic arthritis.
Researchers evaluated the onset of comorbidities and flare patterns, based on baseline comorbidity clusters in patients with gout.
Mortality among immunocompromised adult patients with acute respiratory failure requiring invasive mechanical ventilation was strongly associated with time to intubation.